|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 271.00 USD | -0.27% |
|
+3.18% | +3.23% |
| 01-10 | FluroTech Ltd. Announces Chief Financial Officer Changes | CI |
| 01-08 | BofA Securities Adjusts Ecolab Price Target to $314 From $312, Maintains Buy Rating | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.4 | 5.94 | 5.42 | 6.3 | 7.55 | |||||
Return on Total Capital | 7.29 | 7.85 | 7.07 | 8.25 | 9.85 | |||||
Return On Equity % | 13.19 | 17.01 | 15.28 | 18.17 | 25.29 | |||||
Return on Common Equity | 13.03 | 16.88 | 15.1 | 17.96 | 25.14 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 41.84 | 40.93 | 38.25 | 40.39 | 43.5 | |||||
SG&A Margin | 27.55 | 26.26 | 25.22 | 26.14 | 26.53 | |||||
EBITDA Margin % | 21.18 | 21.29 | 19.65 | 20.28 | 22.9 | |||||
EBITA Margin % | 16.14 | 16.54 | 15.29 | 16.26 | 18.87 | |||||
EBIT Margin % | 14.28 | 14.67 | 13.03 | 14.25 | 16.96 | |||||
Income From Continuing Operations Margin % | 8.35 | 8.98 | 7.82 | 9.09 | 13.54 | |||||
Net Income Margin % | -10.22 | 8.87 | 7.69 | 8.96 | 13.42 | |||||
Net Avail. For Common Margin % | 8.21 | 8.87 | 7.69 | 8.96 | 13.42 | |||||
Normalized Net Income Margin | 7.66 | 8.14 | 6.95 | 7.57 | 9.36 | |||||
Levered Free Cash Flow Margin | 15.55 | 8.65 | 9.26 | 10.14 | 12.28 | |||||
Unlevered Free Cash Flow Margin | 16.73 | 9.62 | 10.37 | 11.57 | 13.63 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.6 | 0.65 | 0.66 | 0.71 | 0.71 | |||||
Fixed Assets Turnover | 3.26 | 3.52 | 3.82 | 3.94 | 3.7 | |||||
Receivables Turnover (Average Receivables) | 5.06 | 5.36 | 5.48 | 5.54 | 5.52 | |||||
Inventory Turnover (Average Inventory) | 5.79 | 5.42 | 5.33 | 5.55 | 6.01 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.75 | 1.32 | 1.3 | 1.3 | 1.26 | |||||
Quick Ratio | 1.26 | 0.84 | 0.83 | 0.91 | 0.89 | |||||
Operating Cash Flow to Current Liabilities | 0.63 | 0.58 | 0.42 | 0.55 | 0.59 | |||||
Days Sales Outstanding (Average Receivables) | 72.26 | 68.11 | 66.59 | 65.9 | 66.26 | |||||
Days Outstanding Inventory (Average Inventory) | 63.16 | 67.38 | 68.42 | 65.75 | 60.94 | |||||
Average Days Payable Outstanding | 57.95 | 60.09 | 62.68 | 68.04 | 69.72 | |||||
Cash Conversion Cycle (Average Days) | 77.48 | 75.4 | 72.33 | 63.61 | 57.48 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 114.69 | 126.23 | 124.36 | 108.19 | 94.24 | |||||
Total Debt / Total Capital | 53.42 | 55.8 | 55.43 | 51.97 | 48.52 | |||||
LT Debt/Equity | 112.39 | 118.98 | 115.91 | 98.82 | 85.61 | |||||
Long-Term Debt / Total Capital | 52.35 | 52.59 | 51.66 | 47.47 | 44.08 | |||||
Total Liabilities / Total Assets | 65.79 | 65.8 | 66.18 | 63.05 | 60.74 | |||||
EBIT / Interest Expense | 7.62 | 9.46 | 7.33 | 6.26 | 7.85 | |||||
EBITDA / Interest Expense | 12.13 | 14.63 | 11.84 | 9.52 | 11.24 | |||||
(EBITDA - Capex) / Interest Expense | 9.92 | 11.38 | 9.01 | 7.3 | 8.31 | |||||
Total Debt / EBITDA | 2.65 | 3.17 | 3.02 | 2.63 | 2.17 | |||||
Net Debt / EBITDA | 2.18 | 3.04 | 2.82 | 2.35 | 1.84 | |||||
Total Debt / (EBITDA - Capex) | 3.25 | 4.07 | 3.97 | 3.43 | 2.93 | |||||
Net Debt / (EBITDA - Capex) | 2.67 | 3.91 | 3.71 | 3.07 | 2.48 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -6.14 | 8 | 11.42 | 7.98 | 2.75 | |||||
Gross Profit, 1 Yr. Growth % | -11.2 | 5.65 | 4.14 | 14.02 | 10.65 | |||||
EBITDA, 1 Yr. Growth % | -12.79 | 8.57 | 2.83 | 11.49 | 15.94 | |||||
EBITA, 1 Yr. Growth % | -17.06 | 10.72 | 2.98 | 14.86 | 19.16 | |||||
EBIT, 1 Yr. Growth % | -19.33 | 10.91 | -1.01 | 18.15 | 22.14 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -31.75 | 16.17 | -3.07 | 25.62 | 53.04 | |||||
Net Income, 1 Yr. Growth % | -177.3 | -193.76 | -3.38 | 25.7 | 53.93 | |||||
Normalized Net Income, 1 Yr. Growth % | -22.79 | 14.73 | -4.92 | 17.72 | 26.94 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -31.62 | 17.42 | -2.56 | 25.72 | 53.86 | |||||
Accounts Receivable, 1 Yr. Growth % | -4.54 | 9 | 8.86 | 5.04 | 1.09 | |||||
Inventory, 1 Yr. Growth % | 18.82 | 16.08 | 20.18 | -16.49 | -2.16 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -3.96 | 3.85 | 1.53 | 7.66 | 11.11 | |||||
Total Assets, 1 Yr. Growth % | -13.14 | 16.99 | 1.22 | 1.78 | 2.48 | |||||
Tangible Book Value, 1 Yr. Growth % | -1.59K | 79.73 | -11.98 | -19.3 | -31.64 | |||||
Common Equity, 1 Yr. Growth % | -29 | 17.15 | 0.16 | 11.17 | 8.86 | |||||
Cash From Operations, 1 Yr. Growth % | -23.15 | 10.84 | -13.26 | 34.86 | 16.67 | |||||
Capital Expenditures, 1 Yr. Growth % | -33.13 | 31.49 | 10.86 | 8.7 | 28.36 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 37.03 | -39.95 | 19.24 | 18.37 | 24.27 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 33.95 | -37.89 | 20.09 | 20.52 | 20.99 | |||||
Dividend Per Share, 1 Yr. Growth % | 2.16 | 3.17 | 5.64 | 4.85 | 9.26 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -1.78 | 0.68 | 9.7 | 9.69 | 5.33 | |||||
Gross Profit, 2 Yr. CAGR % | -3.99 | -3.14 | 4.89 | 8.97 | 12.33 | |||||
EBITDA, 2 Yr. CAGR % | -3.02 | -2.7 | 5.66 | 7.09 | 13.75 | |||||
EBITA, 2 Yr. CAGR % | -5.24 | -4.18 | 6.78 | 8.77 | 17.05 | |||||
EBIT, 2 Yr. CAGR % | -6.45 | -5.42 | 4.78 | 8.17 | 20.2 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -11.8 | -10.96 | 6.11 | 10.35 | 38.66 | |||||
Net Income, 2 Yr. CAGR % | -8.17 | -14.86 | -4.82 | 10.21 | 39.1 | |||||
Normalized Net Income, 2 Yr. CAGR % | -7.24 | -5.88 | 4.44 | 5.8 | 22.24 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -11.69 | -10.4 | 6.96 | 10.68 | 39.08 | |||||
Accounts Receivable, 2 Yr. CAGR % | -7.59 | 2 | 8.93 | 6.94 | 3.05 | |||||
Inventory, 2 Yr. CAGR % | -8.84 | 17.44 | 18.11 | 0.18 | -9.61 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -3.82 | -0.13 | 2.68 | 4.55 | 9.37 | |||||
Total Assets, 2 Yr. CAGR % | -4.98 | 0.8 | 8.82 | 1.5 | 2.13 | |||||
Tangible Book Value, 2 Yr. CAGR % | -0.96 | 418.03 | 25.78 | -15.72 | -25.73 | |||||
Common Equity, 2 Yr. CAGR % | -12.22 | -8.8 | 8.33 | 5.53 | 10.01 | |||||
Cash From Operations, 2 Yr. CAGR % | -9.63 | -7.71 | -1.95 | 8.15 | 25.44 | |||||
Capital Expenditures, 2 Yr. CAGR % | -20.76 | -6.23 | 20.73 | 9.77 | 18.12 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 39.2 | -9.29 | -15.38 | 18.83 | 21.35 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 34.29 | -8.8 | -13.64 | 20.33 | 20.81 | |||||
Dividend Per Share, 2 Yr. CAGR % | 5.75 | 2.67 | 4.4 | 5.25 | 7.03 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -5.19 | 1.37 | 4.14 | 9.12 | 7.33 | |||||
Gross Profit, 3 Yr. CAGR % | -5.34 | -0.88 | -0.77 | 7.85 | 9.53 | |||||
EBITDA, 3 Yr. CAGR % | -5.42 | 0.7 | -0.89 | 7.56 | 9.99 | |||||
EBITA, 3 Yr. CAGR % | -7 | -0.19 | -1.85 | 9.39 | 12.17 | |||||
EBIT, 3 Yr. CAGR % | -6.46 | -0.99 | -3.97 | 9.04 | 12.68 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -13.44 | -3.32 | -8.4 | 12.25 | 23.06 | |||||
Net Income, 3 Yr. CAGR % | -7.13 | -7.53 | -11.2 | 4.43 | 23.19 | |||||
Normalized Net Income, 3 Yr. CAGR % | -7.09 | -0.43 | -5.56 | 8.69 | 12.42 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -13.36 | -2.89 | -7.86 | 12.88 | 23.53 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.02 | -2.36 | 4.24 | 7.62 | 4.95 | |||||
Inventory, 3 Yr. CAGR % | -3.86 | -1.19 | 18.35 | 5.22 | -0.6 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -1.45 | -1.33 | 0.42 | 4.31 | 6.69 | |||||
Total Assets, 3 Yr. CAGR % | -3.17 | 1.85 | 0.94 | 6.42 | 1.82 | |||||
Tangible Book Value, 3 Yr. CAGR % | -7.86 | 20.8 | 186.92 | 8.48 | -21.4 | |||||
Common Equity, 3 Yr. CAGR % | -6.66 | -3.36 | -5.9 | 9.27 | 6.63 | |||||
Cash From Operations, 3 Yr. CAGR % | -3.83 | -3.26 | -9.6 | 9.04 | 10.92 | |||||
Capital Expenditures, 3 Yr. CAGR % | -17.43 | -6.18 | -0.85 | 16.58 | 15.65 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 13.78 | 5.18 | -0.63 | -5.38 | 20.66 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 12.02 | 3.85 | -0.04 | -3.51 | 20.58 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.53 | 4.89 | 3.65 | 4.55 | 6.57 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -2.74 | -0.64 | 0.5 | 4.62 | 4.62 | |||||
Gross Profit, 5 Yr. CAGR % | -5.08 | -1.72 | -1.38 | 2.95 | 4.27 | |||||
EBITDA, 5 Yr. CAGR % | -3.06 | -1.14 | -1.13 | 3.2 | 4.72 | |||||
EBITA, 5 Yr. CAGR % | -4.19 | -1.82 | -1.72 | 3.28 | 5.3 | |||||
EBIT, 5 Yr. CAGR % | -3.92 | -1.55 | -2.12 | 2.56 | 5.04 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -0.65 | -1.7 | -6.09 | 1.93 | 8.12 | |||||
Net Income, 5 Yr. CAGR % | 3.76 | -1.67 | -6.21 | -0.81 | 6.27 | |||||
Normalized Net Income, 5 Yr. CAGR % | -4.17 | -0.81 | -2.64 | 2.02 | 4.71 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 0.06 | -1.14 | -5.74 | 2.32 | 8.64 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.99 | 1.15 | 0.97 | 1.26 | 3.76 | |||||
Inventory, 5 Yr. CAGR % | -1.53 | 2.49 | 4.39 | -0.64 | 6.25 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 1.91 | 1.84 | 0.19 | 0.98 | 3.91 | |||||
Total Assets, 5 Yr. CAGR % | -0.56 | 2.96 | 1.46 | 1.71 | 1.41 | |||||
Tangible Book Value, 5 Yr. CAGR % | -5.25 | 8.94 | 4.36 | 4.6 | 67.11 | |||||
Common Equity, 5 Yr. CAGR % | -2.25 | 0.92 | -0.93 | 0.1 | 0.17 | |||||
Cash From Operations, 5 Yr. CAGR % | -1.44 | 1.23 | -3.08 | 1.15 | 3.06 | |||||
Capital Expenditures, 5 Yr. CAGR % | -8.7 | -3.21 | -3.88 | -0.1 | 6.34 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 5.04 | -7.02 | 1.07 | 10.42 | 7.63 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 4.37 | -7.03 | 0.95 | 10.13 | 7.82 | |||||
Dividend Per Share, 5 Yr. CAGR % | 7.12 | 6.55 | 6.27 | 5.03 | 4.99 |
- Stock Market
- Equities
- ECL Stock
- Financials Ecolab Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















